Report says U.S. government must make strategic domestic, global investments to address TB

In a new report, Protecting the United States from the Health Security Risk of Global Tuberculosis, Audrey Jackson, a senior fellow with the CSIS Global Health Policy Center, discusses the global spread of tuberculosis, including drug-resistant strains, writing, “To be effective in protecting Americans from a costly and potentially deadly disease, the U.S. government must address TB and drug-resistant TB both domestically and globally.” Jackson makes several recommendations for the Trump administration and Congress to “invest strategically in domestic and global TB programs and research and development (R&D) that will contribute to ending the TB epidemic”.